To include your compound in the COVID-19 Resource Center, submit it here.

NBI-34060: Phases I and II

NBIX reported that in a 35-patient, Phase II crossover trial, neither of two

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE